Histone Methyl Modulator Compounds Formula I
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods lack effective modulation of histone methyl modifying enzymes, which are crucial for regulating various biological processes, including gene expression and disease treatment.
Innovation Solution
Development of compounds that stimulate the activity of histone methyl modifying enzymes, including histone methylases and demethylases, with specific chemical structures that can modulate their activity for therapeutic and research purposes.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current methods are used for modulating histone methyl modifying enzymes, then the existing therapeutic approaches can be maintained, but effective modulation of these crucial enzymes cannot be achieved
Solution Approach 1:
The patent employs parameter changes by modifying chemical structures (Formula I compounds) to optimize their interaction with histone methyl modifying enzymes. By systematically varying molecular parameters such as substituent groups, stereochemistry, and functional moieties, the invention achieves effective enzyme modulation while maintaining the necessary biological activity and selectivity
Solution Approach 2:
The patent introduces small molecule compounds as intermediaries that mediate between external therapeutic intervention and the histone methyl modifying enzymes. These compounds act as molecular bridges that can stimulate or inhibit enzyme activity, thereby enabling effective modulation of chromatin structure and gene expression without directly manipulating the enzymes themselves
2Reliability
If compounds of Formula I are developed to stimulate histone methyl modifying enzymes, then effective enzyme modulation is achieved, but the complexity of identifying and optimizing specific chemical structures increases
Solution Approach 1:
The patent applies segmentation by dividing the complex molecular optimization problem into manageable components represented by Formula I. The chemical structure is segmented into defined variables (R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, R12) that can be independently optimized, allowing systematic exploration of structure-activity relationships without overwhelming complexity
Solution Approach 2:
The patent achieves universality by designing Formula I compounds with a core structural framework that can accommodate multiple substituent variations. This universal scaffold can interact with different histone methyl modifying enzymes and regulate various biological processes, reducing the need to develop entirely separate compounds for each target enzyme
Data Source
AI summary
Agents for modulating methyl modifying enzymes, compositions and uses thereof are provided herein.